ReviewCancer cell international2026
Multi-tyrosine kinase inhibitors: exploring immunomodulatory effects on various immune cell types in cancer.
Fatemeh Keshavarz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it